Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the global population and the future clinical and economic consequences are enormous.
Cholangiocarcinoma (CC) is the second most common primary liver tumour. High-quality guidelines are essential for effective patient stratification and individua
There has been a chronic lack of effective treatment for hepatobiliary malignancies, and overall survival of comprehensive therapy, including targeted chemother
IntroductionrnThe safety of donors in living donor liver transplantation (LDLT) is of paramount importance. Although the morbidity of LDLT donors has been drama
Hepatocellular carcinoma (HCC) oncogenesis in the absence of alcoholic liver disease and chronic viral hepatitis has aroused growing clinical conce in clinical
We read with interest the review entitled "Laparoscopic liver resection: the current status and the future" written by Dr. Xiujun Cai and published in Hepatobil